Myoscreen™, a drug discovery platform for disease modeling and the screening of compounds restoring muscle health

被引：0
|
作者：
Flaender, M. [1 ]
Young, J. [1 ]
Duchemin-Pelletier, E. [1 ]
Lorintiu, O. [1 ]
Poydenot, P. [1 ]
机构：
[1] Cytoo, Grenoble, France
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.186
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.130
引用
下载
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] Antimalarial drug discovery: screening of Brazilian medicinal plants and purified compounds
    Krettli, Antoniana Ursine
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (02) : 95 - 108
  • [32] Models and modeling systems in Alzheimer disease drug discovery
    Khachaturian, ZS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 : S9 - S12
  • [33] Engineered skeletal muscles for disease modeling and drug discovery
    Wang, Jason
    Khodabukus, Alastair
    Rao, Lingjun
    Vandusen, Keith
    Abutaleb, Nadia
    Bursac, Nenad
    BIOMATERIALS, 2019, 221
  • [34] DRUG DISCOVERY Terns buys Lilly liver disease compounds
    Jarvis, Lisa
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (15) : 19 - 19
  • [35] Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform
    Antonio Garcia-Leon, Juan
    Vitorica, Javier
    Gutierrez, Antonia
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (11) : 1305 - 1322
  • [36] Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery
    Mondragon-Gonzalez, Ricardo
    Perlingeiro, Rita C. R.
    DISEASE MODELS & MECHANISMS, 2018, 11 (07)
  • [37] Patient-derived lung organoid on a chip platform as a new alternative method for pulmonary disease modeling and drug discovery
    Yang, Seo-Hee
    Eo, Eun-Young
    Park, Ji-Yeon
    Kim, Hyung-Jun
    Cho, Young-Jae
    RESPIROLOGY, 2023, 28 : 171 - 172
  • [38] High Content Screening Platform For Human Engineered Cardiac Tissues Maturation And Drug Discovery
    Zhao, Y.
    Feric, N.
    Aschar-Sobbi, R.
    Zhang, B.
    Conant, G.
    Panhke, A.
    Ronaldson, K.
    Li, F.
    Rekhter, M.
    Vunjak-Novakovic, G.
    Backx, P. H.
    Radicic, M.
    TISSUE ENGINEERING PART A, 2016, 22 : S53 - S53
  • [39] iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery
    Gurevich, Igor
    Burton, Sarah A.
    Munn, Christie
    Ohshima, Makiko
    Goedland, Madelyn E.
    Czysz, Katherine
    Rajesh, Deepika
    BIOLOGY OPEN, 2020, 9 (12):
  • [40] Transporter assays using solid supported membranes:: A novel screening platform for drug discovery
    Kelety, Bela
    Diekert, Kerstin
    Tobien, Joanna
    Watzke, Natalie
    Doerner, Wolfgang
    Obrdlik, Petr
    Fendler, Klaus
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2006, 4 (05) : 575 - 582
12345